KELLY HOSKINS: Open Payments
NPI 1457131930 · MONTICELLO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $63 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $158 |
| Novo Nordisk Inc | 3 | $51 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: CAPLYTA, Rybelsus, Auvelity, Ozempic, LINZESS, MOUNJARO, Qelbree.
Industry payments across MS — which companies pay providers there.
